BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 30829272)

  • 1. Examination of methylation changes of
    Shirkavand A; Boroujeni ZN; Aleyasin SA
    Indian J Cancer; 2018; 55(4):366-371. PubMed ID: 30829272
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DOK7 CpG hypermethylation in blood leukocytes as an epigenetic biomarker for acquired tamoxifen resistant in breast cancer.
    Gowdini E; Aleyasin SA; Ramezani N; Nafisi N; Tutuni M
    J Hum Genet; 2023 Jan; 68(1):33-38. PubMed ID: 36372800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating Cell Free Nuclear DNA, Mitochondrial DNA and Global DNA Methylation: Potential Noninvasive Biomarkers for Breast Cancer Diagnosis.
    Pasha HA; Rezk NA; Riad MA
    Cancer Invest; 2019; 37(9):432-439. PubMed ID: 31516038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA methylation array analysis identifies breast cancer associated RPTOR, MGRN1 and RAPSN hypomethylation in peripheral blood DNA.
    Tang Q; Holland-Letz T; Slynko A; Cuk K; Marme F; Schott S; Heil J; Qu B; Golatta M; Bewerunge-Hudler M; Sutter C; Surowy H; Wappenschmidt B; Schmutzler R; Hoth M; Bugert P; Bartram CR; Sohn C; Schneeweiss A; Yang R; Burwinkel B
    Oncotarget; 2016 Sep; 7(39):64191-64202. PubMed ID: 27577081
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of DNA methylation in promoter regions of hTERT, TWIST1, VIM and NID2 genes in Moroccan bladder cancer patients.
    El Azzouzi M; El Ahanidi H; Hafidi Alaoui C; Chaoui I; Benbacer L; Tetou M; Hassan I; Bensaid M; Oukabli M; Ameur A; Al Bouzidi A; El Mzibri M; Attaleb M
    Cancer Genet; 2022 Jan; 260-261():41-45. PubMed ID: 34922269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA methylation profiling in breast cancer discordant identical twins identifies DOK7 as novel epigenetic biomarker.
    Heyn H; Carmona FJ; Gomez A; Ferreira HJ; Bell JT; Sayols S; Ward K; Stefansson OA; Moran S; Sandoval J; Eyfjord JE; Spector TD; Esteller M
    Carcinogenesis; 2013 Jan; 34(1):102-8. PubMed ID: 23054610
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methylation analysis of plasma cell-free DNA for breast cancer early detection using bisulfite next-generation sequencing.
    Li Z; Guo X; Tang L; Peng L; Chen M; Luo X; Wang S; Xiao Z; Deng Z; Dai L; Xia K; Wang J
    Tumour Biol; 2016 Oct; 37(10):13111-13119. PubMed ID: 27449045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protein expression and methylation of MGMT, a DNA repair gene and their correlation with clinicopathological parameters in invasive ductal carcinoma of the breast.
    Asiaf A; Ahmad ST; Malik AA; Aziz SA; Rasool Z; Masood A; Zargar MA
    Tumour Biol; 2015 Aug; 36(8):6485-96. PubMed ID: 25820821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methylation of SOX1 and VIM promoters in serum as potential biomarkers for hepatocellular carcinoma.
    Liu XY; Fan YC; Gao S; Zhao J; Chen LY; Li F; Wang K
    Neoplasma; 2017; 64(5):745-753. PubMed ID: 28592127
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of expression and aberrant methylation of the CDH1 (E-cadherin) gene in breast cancer patients from Kashmir.
    Asiaf A; Ahmad ST; Aziz SA; Malik AA; Rasool Z; Masood A; Zargar MA
    Asian Pac J Cancer Prev; 2014; 15(15):6397-403. PubMed ID: 25124632
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of the hypermethylation status of PTEN tumor suppressor gene with the risk of breast cancer among Kurdish population from Western Iran.
    Yari K; Payandeh M; Rahimi Z
    Tumour Biol; 2016 Jun; 37(6):8145-52. PubMed ID: 26715274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of 14-3-3 sigma (σ) promoter methylation as a noninvasive biomarker using blood samples for breast cancer diagnosis.
    Ye M; Huang T; Ying Y; Li J; Yang P; Ni C; Zhou C; Chen S
    Oncotarget; 2017 Feb; 8(6):9230-9242. PubMed ID: 27999208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of protein expression and DNA methylation profiles detected by pyrosequencing in invasive breast cancer.
    Zmetakova I; Danihel L; Smolkova B; Mego M; Kajabova V; Krivulcik T; Rusnak I; Rychly B; Danis D; Repiska V; Blasko P; Karaba M; Benca J; Pechan J; Fridrichova I
    Neoplasma; 2013; 60(6):635-46. PubMed ID: 23906298
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methylation of the DCLK1 promoter region in circulating free DNA and its prognostic value in lung cancer patients.
    Powrózek T; Krawczyk P; Nicoś M; Kuźnar-Kamińska B; Batura-Gabryel H; Milanowski J
    Clin Transl Oncol; 2016 Apr; 18(4):398-404. PubMed ID: 26311076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Promoter Methylation of BRCA1, DAPK1 and RASSF1A is Associated with Increased Mortality among Indian Women with Breast Cancer.
    Yadav P; Masroor M; Nandi K; Kaza RCM; Jain SK; Khurana N; Saxena A
    Asian Pac J Cancer Prev; 2018 Feb; 19(2):443-448. PubMed ID: 29480000
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aberrant DNA methylation and expression of SPDEF and FOXA2 in airway epithelium of patients with COPD.
    Song J; Heijink IH; Kistemaker LEM; Reinders-Luinge M; Kooistra W; Noordhoek JA; Gosens R; Brandsma CA; Timens W; Hiemstra PS; Rots MG; Hylkema MN
    Clin Epigenetics; 2017; 9():42. PubMed ID: 28450970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blood-based DNA methylation as biomarker for breast cancer: a systematic review.
    Tang Q; Cheng J; Cao X; Surowy H; Burwinkel B
    Clin Epigenetics; 2016; 8():115. PubMed ID: 27895805
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Detection and significance of APC gene promoter hypermethylation in serum of breast cancer patients].
    Zhang JJ; Ouyang T; Wan WH; Xu GW; Deng GR
    Ai Zheng; 2007 Jan; 26(1):44-7. PubMed ID: 17222366
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical significance of promoter hypermethylation of DNA repair genes in tumor and serum DNA in invasive ductal breast carcinoma patients.
    Sharma G; Mirza S; Parshad R; Srivastava A; Gupta SD; Pandya P; Ralhan R
    Life Sci; 2010 Jul; 87(3-4):83-91. PubMed ID: 20470789
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypermethylation of ITGA4, TFPI2 and VIMENTIN promoters is increased in inflamed colon tissue: putative risk markers for colitis-associated cancer.
    Gerecke C; Scholtka B; Löwenstein Y; Fait I; Gottschalk U; Rogoll D; Melcher R; Kleuser B
    J Cancer Res Clin Oncol; 2015 Dec; 141(12):2097-107. PubMed ID: 25902909
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.